MÖLNDAL, Sweden, Aug. 28, 2025 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2025/26 results on September 1, 2025 at ...

The third quarter has been characterized by record sales figures, mainly driven by our continued expansion in the US and a recent accelerating growth in emerging markets. Yet another quarter with ...

MÖLNDAL, Sweden, Sept. 1, 2025 /PRNewswire/ -- When publishing the interim report for the company, it was discovered that some of the total sums in the income statement show the wrong amounts. The sum ...

Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing ...

In July, OsteoCentric Oncology and Bone Anchored Prostheses, LLC announced that it had made a public offer for Integrum. Shortly thereafter, Integrum's bid committee stated that the offer represented ...

Earnings call Integrum reported SEK 23.8M in Q1 revenue, up 28.9% YoY, with U.S. sales growing 41.2% (56% in USD). Gross margin declined to 67% due to tariffs. S1 surgeries rose 10% YoY, and ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...